Clin2
NCT07769268Possibly a fitRecruiting

Cream for treating dark spots on the face

HyperpigmentationMelasma (Facial Melasma)

Part of Skin clinical trials.

This study tests a cosmetic cream to reduce dark spots on the face, including melasma and sun spots. It aims to see if the product improves the appearance of hyperpigmentation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
30 years to 60 years
Study type
Interventional

Who can take part

  • You are a woman between 30 and 60 years old.
  • You have dark spots on your face, such as melasma, sun spots, or spots after inflammation.
  • You are available for in-person visits and phone or video check-ins.
  • You are not pregnant, breastfeeding, or planning to become pregnant.
  • You have not used certain medications (anti-inflammatories, immunosuppressants, antihistamines) in the last 3 weeks.
  • You have not had any facial treatments (like peels or laser) in the last 4 weeks or intense sun exposure in the last 15 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07696806Enrolling by invitation· Phase 4
Needle-assisted treatment for melasma using common skin medications

This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.

Tanta
NCT07429786Not yet recruiting
MelaB3 Serum with glycolic acid peel for skin darkening

This study tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for different types of dark skin patches (like melasma, dark marks after acne, or sun spots). Participants will have several treatments and be monitored for about a few months.

NCT07485777Not yet recruiting
Metformin cream vs. standard melasma treatment in women

This study compares a metformin cream to a standard treatment (Kligman's regimen) for reducing melasma, a common skin condition causing dark patches on the face. It aims to find which treatment is more effective for women with this condition.

Rawalpindi, Punjab Province
NCT07071363Recruiting
Serum vs hydroquinone for melasma treatment

This trial compares a new cosmetic serum to a standard treatment (4% hydroquinone) for facial melasma over 84 days. It may help if you have mild to moderate melasma and are looking for a gentler alternative.

Port Louis, Phoenix
NCT07202156Recruiting
Ultrasound helps deliver melasma treatment

This trial tests a new way to deliver a medicine (tranexamic acid) into melasma patches using ultrasound waves. It aims to see if the ultrasound helps the medicine work better to lighten the dark spots.

Nanjing, Jiangsu
NCT07679945Recruiting
Study of facial sunscreen for dark spots

This study tests whether a facial sunscreen can reduce dark spots and pigmentation after 8 weeks of daily use. It may be a good option if you have age spots, melasma, or other dark marks on your face and want a simple, non-invasive treatment.

Campinas, São Paulo

Hear when a new Hyperpigmentation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.